HOME >> BIOLOGY >> NEWS
June meeting to explore how science, technology inspire art; promote new art forms

NEW BRUNSWICK/PISCATAWAY, N.J. Following in Leonardo da Vinci's footsteps, modern scientists and artists will meet in New Brunswick, N.J., USA in June to share their work and explore how science and technology continue to inspire art and make new forms of art possible.

Organized by Rutgers University professors, the Fourth International Symposium of Science and Art will examine how scientific images, such as microscopic views of molecules, natural and computer displays of fluid motion, and glimpses of far-off galaxies, become the subjects of paintings, photographs, animation and sculpture. The conference also will look at how new materials, computer software and other technical advances lead to new forms of artistic expression.

"Examples abound of artists being inspired by science and drawing on technology to portray their ideas in classical and modern media," said Norman Zabusky, mechanical engineering professor of computational fluid dynamics and conference director. "We're bringing together scientists who appreciate the artistic merit in the subjects they're exploring with artists who see beauty in the latest scientific discoveries. Together, they'll share ideas and draw inspiration in venues ranging from scholarly talks to gallery presentations and museum visits."

The symposium, to be held June 9-12 at the Hyatt-Regency Hotel in downtown New Brunswick, is accepting advance registrations through May 15. Applications to exhibit art work or present conference papers are due Feb. 21. These can be made at the meeting web site, www.mechanical.rutgers.edu/scart4.

As an expert in fluid physics, Zabusky long ago noticed how the images he created to grasp scientific principles had a certain kind of beauty. Contrary to the stereotype that scientific and artistic personalities don't mix, he shared his work with artists and developed a strong rapport. At the last symposium, Zabusky delivered the keynote address on fluid and wave imagery, noti
'"/>

Contact: Carl Blesch
cblesch@ur.rutgers.edu
732-932-7084 x616
Rutgers, the State University of New Jersey
14-Feb-2005


Page: 1 2

Related biology news :

1. Chemical Society Boston meeting, Aug. 19-23, focuses on health, wellness, energy, environment
2. Almac Diagnostics attends pre-IDE meeting with FDA
3. Media events planned for 2007 American Society of Gene Therapy meeting, May 30-June 3
4. SNM capitalizes opportunity to meet with policymakers, regulators at annual meeting in D.C.
5. Data presented at ISHLT meeting confirm RNA analysis can identify rejection in lung transplant recip
6. Developed/emerging market biotech firms convene at largest-ever meeting with global health focus
7. AACR, FDA and NCI announce cancer biomarkers collaborative at the AACR 2007 annual meeting
8. AACR hosts annual meeting 2007
9. Press conferences at the years largest physics meeting
10. Largest physics meeting of the year, in Denver
11. Neuroscientist Robert Sapolsky will discuss stress, health, Feb. 17 at AAAS meeting

Post Your Comments:
(Date:5/23/2013)... By discovering the new mechanism by which estrogen suppresses ... revealed a potential new approach toward treating certain liver ... and colleagues believe they are changing long-held views in ... issue of the journal Science Signaling . , ... years has been that only receptors located in the ...
(Date:5/23/2013)... Some prostate cancer patients unnecessarily undergo surgery or ... differences between slow-growing and aggressive forms of the ... Johns Hopkins Medical Institutes are developing technology that ... opt for relatively mild treatments or take drastic ... Anant Madabhushi, an associate professor of biomedical engineering ...
(Date:5/23/2013)... world are billions of animal and plant specimens from ... all stacked, stored and preserved in jars and collection ... critical to understanding how the Earth,s biodiversity is changing ... if only the information were easily accessible. , A ... of a team from the University of Colorado Boulder, ...
Breaking Biology News(10 mins):UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 4
(Date:5/23/2013)... -- BioScrip, Inc. (NASDAQ: BIOS ) today announced ... Global Healthcare Conference to be held June 3-6, 2013 ... Richard Smith , President and Chief Executive ... Financial Officer, will present on Monday, June 3, 2013 ... About BioScrip BioScrip, Inc. provides comprehensive infusion and ...
(Date:5/23/2013)... , May 23, 2013  Rahal Letterman Lanigan Racing ... cord blood stem cell banking and therapeutics, announced today ... No. 16 Acorn Stairlifts Indy car driven by ... remainder of the IZOD IndyCar 2013 season.   ... work to support awareness of umbilical cord blood banking ...
(Date:5/23/2013)... , May 23, 2013 Virobay, Inc. today ... pain has reached an important milestone, as Virobay has ... - a selective cathepsin S inhibitor.   ... double-blind, randomized, placebo-controlled study designed to evaluate the safety, ... in healthy adults. "The initiation of this ...
(Date:5/23/2013)... May 23, 2013 The New Jersey ... industries, Black Data Processing Associates (BDPA), is hosting its ... 8, 2013. This all-day event will encourage students and ... the ins and outs from many of the industries’ ... at the New Jersey Institute of Technology, the event ...
Breaking Biology Technology:StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Black Data Processing Associates (BDPA) New Jersey Hosts 10th Annual Families in Technology Day June 8, 2013 2
Cached News: